Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dovitinib in Advanced Scirrhous Gastric Carcinoma
NCT01576380Phase 2Completed
- Sponsor
- Novartis
- Start
- Jun 2012
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dovitinib in scirrhous gastric carcinoma (SGC), sponsored by Novartis. Started Jun 2012; status: completed.
02
Drugs
dovitinib
03
Conditions
scirrhous gastric carcinoma (SGC)
Beyond the preview
Go deeper on NCT01576380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01576380.